Clinical Trials Logo

Clinical Trial Summary

Influenza virus infections are a major cause of morbidity and mortality. The limited existing knowledge about the impact of influenza in immunocompromised patients suggests that they are at increased risk of influenza virus acquisition, of developing complications and of prolonged illness and viral shedding. However, some other data about the effect of antiviral agents on the infection course, and risk of resistance in immunocompromised children are lacking. The emergence of the pandemic H1N1 swine-origin influenza A virus has generated an additional need to study the epidemiology, clinical course and outcome of influenza infections in immunocompromised children. This study proposed to conduct a prospective observational clinical study to answer these questions.


Clinical Trial Description

This study aims to do the following;

- To evaluate the frequency of influenza virus infections due to various subtypes in immunocompromised children and young adults at SJCRH

- To describe and compare the clinical course and outcome of pandemic H1N1 influenza infection with that due to other influenza virus subtypes in immunocompromised children and young adults.

- To evaluate the duration of influenza virus shedding in immunocompromised children and young adults.

- To evaluate the immunologic response to natural infection with various subtypes of influenza virus including the pandemic H1N1 influenza A virus.

- To evaluate the viral resistance to antiviral agents in relation to antiviral therapy.

- To compare accuracy of rapid methods for influenza A subtyping and for determination of antiviral resistance. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00998803
Study type Observational
Source St. Jude Children's Research Hospital
Contact
Status Completed
Phase N/A
Start date October 2009
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT00760175 - Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients N/A
Completed NCT01964989 - Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children. Phase 3
Recruiting NCT05375006 - Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant Culture
Completed NCT01561807 - A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus Phase 2